featured
Cardiovascular Safety of Novel Hormonal Agents in mCRPC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Genitourinary Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparative Cardiovascular Safety of Novel Hormonal Agents in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Clin Genitourin Cancer 2022 Feb 01;20(1)17-24, J Hu, AG Aprikian, M Vanhuyse, A DragomirFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.